renegade.bio

About:

Renegade.bio provides rapid and cost-effective diagnostic testing for detection of novel infectious diseases.

Top Investors: SOSV, FinRebel

Description:

Renegade.bio is a biotechnology startup dedicated to developing and deploying high throughput diagnostics for the detection of novel infectious diseases.

Total Funding Amount:

$1.13M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Berkeley, California, United States

Founded Date:

2020-03-18

Contact Email:

craig(AT)renegade.bio

Founders:

Craig Rouskey, Gabriel Paulino, Julia Russotti

Number of Employees:

11-50

Last Funding Date:

2023-03-01

IPO Status:

Private

Industries: